MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
Chemistry World
February 25, 2015
Rebecca Trager
US opens up home DNA screening The US Food and Drug Administration has, for the first time, authorized a genetic test to be sold directly to consumers. The agency plans to ease the regulatory path for similar screening tests. mark for My Articles similar articles
Fast Company
John Paul Titlow
23andMe Wants To Turn Your DNA Data Into Lucrative New Drugs 23andMe's original business model may have been thwarted by the feds, but that isn't stopping the company from trying new ways to generate revenue. Its latest idea could be a lucrative one: invent new drugs. mark for My Articles similar articles
Fast Company
David Lumb
The FDA Just OK'd 23AndMe To Test For One Syndrome The FDA just gave consumer genetics testing company 23AndMe permission to sell tests for Bloom syndrome -- a disease associated with shortened height and an increased cancer risk. mark for My Articles similar articles
Fast Company
Elizabeth Segran
23andMe And The FDA Reached A Pivotal Genetic Testing Agreement An FDA decision summary allows DNA-testing company 23andMe to market a genome test that screens for Bloom syndrome, a rare disorder that may lead toward the development of cancer. mark for My Articles similar articles
Pharmaceutical Executive
September 1, 2010
The Testing of the Tests FDA seeks to regulate genetic tests more actively, while encouraging diagnostic development. mark for My Articles similar articles
The Motley Fool
May 28, 2010
Brian Orelli
Is It Time to Make Money Investing in Genetic Testing? Easier said than done. mark for My Articles similar articles
The Motley Fool
June 14, 2010
Bruce Bigelow
Genetic Testing Companies in San Diego, Boston, and San Francisco Studying FDA Letters The letters notify the companies that genome-sequencing tests they offer to consumers are medical devices that require the agency's approval. mark for My Articles similar articles
BusinessWeek
January 21, 2010
Rich Jaroslovsky
Web DNA Tests Offer Ease and Enlightenment A comparison of the often entertaining services of Navigenics, 23andMe, and deCODEme. mark for My Articles similar articles
AskMen.com
Jacob Franek
Genetic Testing Every day the prospect of individualized genetic testing is slowly becoming commonplace, and certain questions about genetic testing are apparent: What kinds of tests are available? Where can I get them? How accurate are they? And what are the costs? mark for My Articles similar articles
The Motley Fool
May 30, 2007
Rick Aristotle Munarriz
Warren Buffett Is No Parrothead Jimmy Buffett and Warren Buffett aren't related. Solving the Buffett mystery illustrates how a stake in 23andMe is a good fit in Google's portfolio. Investors, take note. mark for My Articles similar articles
Fast Company
David Lumb
Apple Is Planning iPhone Apps That Let You Share Your DNA Down the line, these apps could let users share their DNA data just like iPhone users share their locations now, says MIT Technology Review. mark for My Articles similar articles
Fast Company
November 2013
Elizabeth Murphy
To Know You Is To Really Know You A deeper look at the makeup of genetic testing firm 23andme's customers and what their DNA reveals. mark for My Articles similar articles
Fast Company
November 2013
Elizabeth Murphy
Inside 23andMe founder Anne Wojcicki's $99 DNA Revolution If Wojcicki gets it right, 23andMe could help change the health care industry as we know it. "At $99, we are opening the doors of access," she says. "Genetics is part of an entire path for how you're going to live a healthier life." mark for My Articles similar articles
Pharmaceutical Executive
May 1, 2005
Thought Leaders: Playing Field in Biotech/Pharma Partnerships Levels As infrastructure and business savvy within biotechs become increasingly sophisticated, the sector's relationship with pharma is taking on a new shape. An interview with industry veteran Lisa Drakeman on how to integrate cultures and processes and where pharma is falling short. mark for My Articles similar articles
BusinessWeek
November 25, 2009
Arlene Weintraub
Can Roche Leave Genentech Alone? Now that Roche has acquired the biotech superstar, success will depend on keeping some distance. mark for My Articles similar articles
The Motley Fool
November 30, 2010
Brian Orelli
Better Buy: Exact Sciences or Sequenom? A battle of the diagnostic test makers. mark for My Articles similar articles
Wired
November 17, 2007
Thomas Goetz
23AndMe Will Decode Your DNA for $1,000. Welcome to the Age of Genomics A much-anticipated Silicon Valley startup called 23andMe offers a thorough tour of your genealogy, tracing your DNA back through the eons. mark for My Articles similar articles
Fast Company
Pavithra Mohan
App Used 23andMe's DNA Database To Block People From Sites Based On Race And Gender Personal genetics company 23andMe discovered that a programmer had used its open API to create a screening mechanism for websites -- which could effectively block people by race, sex, and ancestry. mark for My Articles similar articles